Emma R. Wilson

Emma R. Wilson

Auto-generated profile, based on publicly available information

Emma R. Wilson

Hunter James Kelly Research Institute, University at Buffalo

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Ultramicroscopy
Verified
Journal Article
Open access
CPChristopher J. Peddie
Christopher J. Peddie
KBKen Blight
Ken Blight
EWEmma Wilson
Emma Wilson
CMCharlotte Melia
Charlotte Melia
JMJo Marrison
Jo Marrison
LCLucy Collinson
Lucy Collinson
Fluorescence microscopy of GFP-tagged proteins is a fundamental tool in cell biology, but without seeing the structure of the surrounding cellular space, functional information can be lost. Here we present a protocol that preserves GFP and mCherry fluorescence in mammalian cells embedded in resin with electron contrast to reveal cellular ultrastructure. Ultrathin in-resin fluorescence (IRF) sections were imaged simultaneously for fluorescence and electron signals in an integrated light and scanning electron microscope. We show, for the first time, that GFP is stable and active in resin sections in vacuo. We applied our protocol to study the subcellular localisation of diacylglycerol (DAG), a modulator of membrane morphology and membrane dynamics in nuclear envelope assembly. We show that DAG is localised to the nuclear envelope, nucleoplasmic reticulum and curved tips of the Golgi apparatus. With these developments, we demonstrate that integrated imaging is maturing into a powerful tool for accurate molecular localisation to structure.

12 April 2020 in Developmental Neurobiology
Verified
Journal Article
Closed access
PDF file
EWEmma R. Wilson
Emma R. Wilson
Gustavo Della-Flora NunesGustavo Della-Flora Nunes
Gustavo Della-Flora Nunes
MWMichael R. Weaver
Michael R. Weaver
LFLuciana R. Frick
Luciana R. Frick
MFM. Laura Feltri
M. Laura Feltri

1 September 2018 in Neurobiology of Disease
Verified
Journal Article
Open access
EWEmma R. Wilson
Emma R. Wilson
UKUmaiyal Kugathasan
Umaiyal Kugathasan
AAAndrey Y. Abramov
Andrey Y. Abramov
ACAlex J. Clark
Alex J. Clark
DBDavid L.H. Bennett
David L.H. Bennett
BKBernadett Kalmar
Bernadett Kalmar
Hereditary sensory neuropathy type 1 (HSN-1) is a peripheral neuropathy most frequently caused by mutations in the SPTLC1 or SPTLC2 genes, which code for two subunits of the enzyme serine palmitoyltransferase (SPT). SPT catalyzes the first step of de novo sphingolipid synthesis. Mutations in SPT result in a change in enzyme substrate specificity, which causes the production of atypical deoxysphinganine and deoxymethylsphinganine, rather than the normal enzyme product, sphinganine. Levels of these abnormal compounds are elevated in blood of HSN-1 patients and this is thought to cause the peripheral motor and sensory nerve damage that is characteristic of the disease, by a largely unresolved mechanism. In this study, we show that exogenous application of these deoxysphingoid bases causes dose- and time-dependent neurotoxicity in primary mammalian neurons, as determined by analysis of cell survival and neurite length. Acutely, deoxysphingoid base neurotoxicity manifests in abnormal Ca2+ handling by the endoplasmic reticulum (ER) and mitochondria as well as dysregulation of cell membrane store-operated Ca2+ channels. The changes in intracellular Ca2+ handling are accompanied by an early loss of mitochondrial membrane potential in deoxysphingoid base-treated motor and sensory neurons. Thus, these results suggest that exogenous deoxysphingoid base application causes neuronal mitochondrial dysfunction and Ca2+ handling deficits, which may play a critical role in the pathogenesis of HSN-1.

15 June 2021 in Journal of Anatomy
Verified
Journal Article
Open access
PDF file
CRChelsey B. Reed
Chelsey B. Reed
MFM. Laura Feltri
M. Laura Feltri
EWEmma R. Wilson
Emma R. Wilson
Recent years have seen an evolving appreciation for the role of glial cells in the nervous system. As we move away from the typical neurocentric view of neuroscience, the complexity and variability of central nervous system glia is emerging, far beyond the three main subtypes: astrocytes, oligodendrocytes, and microglia. Yet the diversity of the glia found in the peripheral nervous system remains rarely discussed. In this review, we discuss the developmental origin, morphology, and function of the different populations of glia found in the peripheral nervous system, including: myelinating Schwann cells, Remak Schwann cells, repair Schwann cells, satellite glia, boundary cap‐derived glia, perineurial glia, terminal Schwann cells, glia found in the skin, olfactory ensheathing cells, and enteric glia. The morphological and functional heterogeneity of glia found in the periphery reflects the diverse roles the nervous system performs throughout the body. Further, it highlights a complexity that should be appreciated and considered when it comes to a complete understanding of the peripheral nervous system in health and disease.

2 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
Gustavo Della-Flora NunesGustavo Della-Flora Nunes
Gustavo Della-Flora Nunes
EWEmma R. Wilson
Emma R. Wilson
LMLeandro N. Marziali
Leandro N. Marziali
EHEdward Hurley
Edward Hurley
NSNicholas Silvestri
Nicholas Silvestri
MFM. Laura Feltri
M. Laura Feltri
In peripheral nerves, Schwann cells form myelin and provide trophic support to axons. We previously showed that the mitochondrial protein prohibitin 2 can localize to the axon-Schwann-cell interface and is required for developmental myelination. Whether the homologous protein prohibitin 1 has a similar role, and whether prohibitins also play important roles in Schwann cell mitochondria is unknown. Here, we show that deletion of prohibitin 1 in Schwann cells minimally perturbs development, but later triggers a severe demyelinating peripheral neuropathy. Moreover, mitochondria are heavily affected by ablation of prohibitin 1 and demyelination occurs preferentially in cells with apparent mitochondrial loss. Furthermore, in response to mitochondrial damage, Schwann cells trigger the integrated stress response, but, contrary to what was previously suggested, this response is not detrimental in this context. These results identify a role for prohibitin 1 in myelin integrity and advance our understanding about the Schwann cell response to mitochondrial damage.

10 April 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RMRoope Männikkö
Roope Männikkö
ZSZakhar O. Shenkarev
Zakhar O. Shenkarev
MTMichael G. Thor
Michael G. Thor
ABAntonina A. Berkut
Antonina A. Berkut
MMMikhail Yu Myshkin
Mikhail Yu Myshkin
AVAlexander Vassilevski
Alexander Vassilevski
Significance: Voltage-gated ion channels contain domains that have discrete functionalities. The central pore domain allows current flow and provides ion selectivity, whereas peripherally located voltage-sensing domains (VSDs) are needed for voltage-dependent gating. Certain mutations trigger a leak current through VSDs, known as gating pore current. Hypokalemic periodic paralysis (HypoPP) type 2 is caused by mutations in the skeletal muscle voltage-gated sodium channel Na V 1.4 that neutralize positive charges in S4 voltage-sensing segments of VSDs. We show that Hm-3 toxin from the crab spider Heriaeus melloteei inhibits gating pore currents through such mutant channels. We propose that Hm-3 and similar toxins may constitute useful hits in developing gating pore current inhibitors and HypoPP therapy.